Meeder Asset Management Inc 10x Genomics, Inc. Transaction History

Meeder Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $14,298 - $24,201	586 New	586 $21,000
Q2 2022 Aug 08, 2022	BUY	$36.95 - $82.41 $1,588 - $3,543	43 Added 116.22%	80 $4,000
Q1 2022 May 10, 2022	BUY	$55.7 - $145.79 $2,060 - $5,394	37 New	37 $3,000
Q4 2021 Feb 11, 2022	SELL	$135.05 - $182.59 $945 - $1,278	-7 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$145.58 - $192.14 $436 - $576	-3 Reduced 30.0%	7 $1,000
Q1 2021 Apr 28, 2021	BUY	$140.25 - $196.86 $140 - $196	1 Added 11.11%	10 $2,000
Q4 2020 Feb 09, 2021	BUY	$126.47 - $163.7 $1,138 - $1,473	9 New	9 $1,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.